Physician profile
Charles Orth
NPI 1952375230
$3,759.79
in general payments reported to CMS, 2019-2025
14 companies · $489 in 2025
The $489 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $110 · 2020: $64.03 · 2021: $1,419 · 2022: $79.57 · 2023: $801 · 2024: $798 · 2025: $489.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,073 · Education: $14.40.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,073.39 |
| Education | $14.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $1,207.88 | 2019-2025 | Blueprint Patient Specific Instrumentation, Variax, Gamma |
| Titan Surgical Group, LLC | $1,200.00 | 2021 | |
| Zimmer Biomet Holdings, INC. | $201.82 | 2022-2023 | |
| Bioventus LLC | $177.03 | 2024-2025 | Exogen Ultrasound Bone Healing System |
| Acumed LLC | $144.52 | 2025 | Acumed, Innate Implant |
| Skeletal Dynamics INC | $123.77 | 2023 | Ijs, Geminus, Align |
| Si-Bone, INC. | $120.87 | 2024 | |
| Linvatec Corporation | $117.90 | 2024 | Biobrace 23mm |
| Innovation Technologies INC | $106.14 | 2023 | Irrisept |
| Biocomposites INC | $101.12 | 2025 | Stimulan |
| Kerecis Limited | $99.07 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Wright Medical Technology, INC. | $84.34 | 2019 | |
| Depuy Synthes Sales INC. | $58.22 | 2021-2024 | |
| Boston Scientific Corporation | $17.11 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Charles Orth listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.